NCT00897221View on ClinicalTrials.gov

A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia

PHASE2CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

June 30, 2009

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Friedreich's Ataxia
Interventions
DRUG

Deferiprone oral solution 100mg/mL

Deferiprone oral solution (20 mg/kg/day)

DRUG

Deferiprone oral solution 100 mg/mL

Deferiprone oral solution(40mg/kg/day)

Trial Locations (4)

Unknown

Hospital Erasme, Brussels

Hospital Necker-Enfants Malades, Paris

"Fondazione IRCCS Istituto Neurologico C. Besta", Milan

La Fundacion Para la Investigacion Biomedica, Madrid

Sponsors

Lead Sponsor

ApoPharma
All Listed Sponsors
lead

ApoPharma

INDUSTRY

NCT00897221 - A Study Investigating the Long-term Safety and Efficacy of Deferiprone in Patients With Friedreich's Ataxia | Biotech Hunter | Biotech Hunter